Rough Month: A Closer Look At Ligand's Fall From All-Time Highs By: Benzinga via Benzinga August 24, 2016 at 15:49 PM EDT Shares of Mylan NV (NASDAQ: MYL) have tumbled 10 percent this week over concerns regarding its huge price increase for its Epipen ... Read More >> Related Stocks: Ligand Pharm Mylan Nasdaq Biotechnology Ishares ETF